1

    10X Genomics Inc (TXG)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $62.45
    +0.91 (+1.48%)

    Market Cap: $8.02B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    69%(20/29)
    Avg Surprise
    +19.17%
    Streak
    6 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.02
    Range$-0.04 - $0.00
    3 analysts
    EPS RevisionsNo revisions (7d)
    1
    1
    30d
    EPS Estimate Drift
    90d ago$-0.04-119.8%
    60d ago$-0.04-119.8%
    30d ago$-0.04-119.8%
    7d ago$-0.04-119.8%
    Current$-0.02
    Revenue Consensus
    $147M
    Range$146M - $149M
    14 analysts
    Dec 31, 2026
    EPS Consensus$0.20
    Range$0.12 - $0.27
    2 analysts
    Revenue Consensus
    $180M
    Range$177M - $183M
    15 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.20---
    Sep 26EST
    		-$-0.02---
    Jun 26
    		$-0.14$-0.23+39.13%Beat-150.0%
    Mar 26
    		$0.07$-0.06+216.67%Beat+170.0%
    Dec 25
    		$0.07$-0.04+275.00%Beat+150.0%
    Sep 25
    		$-0.02N/A+71.43%Beat+0.0%
    Jun 25
    		$0.28$-0.35+180.00%Beat+2700.0%
    Mar 25
    		$-0.10N/A+65.52%Beat+50.0%
    Dec 24
    		$-0.14$-0.11-27.27%Miss+65.9%
    Sep 24
    		$-0.02N/A+92.31%Beat+80.0%
    Jun 24
    		$0.01N/A+104.35%Beat+107.1%
    Mar 24
    		$-0.20$-0.39+48.72%Beat-185.7%
    Dec 23
    		$-0.41$-0.36-13.89%Miss-295.2%
    Sep 23
    		$-0.10$-0.04-150.00%Miss-42.9%
    Jun 23
    		$-0.14$-0.05-180.00%Miss+44.0%
    Mar 23
    		$-0.07N/A+56.25%Beat+50.0%
    Dec 22
    		$0.21$-0.20+205.00%Beat+231.3%
    Sep 22
    		$-0.07N/A+70.83%Beat+53.3%
    Jun 22
    		$-0.25$-0.30+16.67%Beat-127.3%
    Mar 22
    		$-0.14N/A+57.58%Beat-27.3%
    Dec 21
    		$-0.16$-0.03-433.33%Miss-100.0%
    Sep 21
    		$-0.15$-0.21+28.57%Beat+40.0%
    Jun 21
    		$-0.11N/A+52.17%Beat+73.2%
    Mar 21
    		$-0.11$-0.19+42.11%Beat+45.0%
    Dec 20
    		$-0.08$-0.07-14.29%Miss-14.3%
    Sep 20
    		$-0.25$-0.31+19.35%Beat+24.2%
    Jun 20
    		$-0.41$-0.49+16.33%Beat-156.2%
    Mar 20
    		$-0.20$-0.13-53.85%Miss-
    Dec 19
    		$-0.07$-0.13+46.15%Beat-
    Sep 19
    		$-0.33$-0.10-230.00%Miss-
    Jun 19
    		$-0.16$-0.11-45.45%Miss-

    Key Metrics

    Valuation
    P/E Ratio-3122.50EV/EBITDA148.50x
    Price/FCF66.85xFCF Yield1.50%
    Profitability
    Profit Margin-12.20%Operating Margin-15.20%
    ROE-9.40%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage32265.00x
    Current Ratio5.69xQuick Ratio5.25x
    Trading Statistics
    Beta2.04Avg Volume3.26M
    52-Week High$66.9452-Week Low$11.16

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$62.84
    SMA 20$58.42
    SMA 50$48.63
    SMA 200$28.02
    EMA 10$62.01
    EMA 20$58.70
    EMA 50$50.03
    EMA 200$31.93

    MACD

    Line: 4.68Signal: 4.92Hist: -0.25

    ADX

    ADX: 47.1+DI: 26.2-DI: 14.7

    Aroon & PSAR

    Aroon Up84.0
    Aroon Down36.0
    PSAR$66.94

    Bollinger Bands

    Upper Band$70.64
    Lower Band$46.20
    %B Position4184%(Upper)
    Band Width0.66

    RSI (14-Day)

    Neutral
    63.2

    Momentum Oscillators

    Stoch %K67.5
    Stoch %D77.4
    Williams %R-38.4
    ROC (10d)7.7%
    Momentum4.46
    CCI (20d)46.5
    MFI (14d)47.0

    Volatility Measures

    ATR (14d)$3.68(5.9%)
    StdDev (20d)6.11
    Hist Vol85.9%(High)

    Volume Flow

    VWAP$61.26
    OBV111.3M
    AD Line114.3M
    CMF (20d)0.297

    Volume Metrics

    Avg Vol (20d)3.2M
    Vol Ratio0.8x
    VWMA (20d)$58.66

    Pivot Points

    R3$68.27
    R2$66.63
    R1$64.09
    Pivot Point$62.45
    S1$59.91
    S2$58.27
    S3$55.73

    Advanced Oscillators

    TSI36.67
    Ultimate Osc63.4
    KST369.05

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$151.04M$150.84M$166.03M$149.00M$172.91M$154.88M$165.02M$151.65M$153.10M$141.01M$183.98M$153.64M
    Cost of Revenue$38.54M$44.66M$52.98M$48.70M$47.82M$49.44M$54.07M$45.26M$48.88M$48.09M$68.20M$58.12M
    Gross Profit$112.50M$106.18M$113.05M$100.31M$125.08M$105.44M$110.95M$106.39M$104.22M$92.91M$115.78M$95.53M
    Operating Expenses$132.05M$123.22M$132.59M$132.55M$94.96M$144.77M$160.79M$147.88M$145.96M$154.41M$170.97M$190.32M
    R&D$56.79M$56.85M$55.97M$57.19M$61.22M$64.25M$66.97M$66.17M$62.92M$68.64M$84.84M$107.91M
    SG&A$78.66M$66.38M$76.62M$75.36M$74.43M$89.73M$93.83M$81.70M$83.04M$85.77M$86.13M$82.42M
    Operating Income$-19,555,000$-17,046,000$-19,541,000$-32,242,000$30.13M$-39,328,000$-49,839,000$-41,485,000$-41,737,000$-61,498,000$-55,188,000$-94,795,000
    Interest Income$4.80M$5.01M$6.89M$5.20M$4.27M$3.69M$4.51M$4.97M$4.71M$4.74M$4.62M$4.30M
    Interest Expense$0$0$0$-3,000$3,000$0$0$2,000$1,000$1,000$0$0
    Income Before Tax$-18,645,000$-12,847,000$-15,193,000$-28,205,000$37.00M$-33,506,000$-48,380,000$-34,438,000$-37,079,000$-57,803,000$-46,598,000$-91,744,000
    Income Tax Expense$-714,000$623,000$1.06M$-733,000$2.46M$852,000$648,000$1.31M$818,000$2.15M$2.35M$1.24M
    Net Income$-17,931,000$-13,470,000$-16,252,000$-27,472,000$34.54M$-34,358,000$-49,028,000$-35,753,000$-37,897,000$-59,949,000$-48,952,000$-92,986,000
    EBITDA$-13,778,000$-5,951,000$-9,985,000$-21,156,000$42.38M$-27,378,000$-42,324,000$-28,657,000$-30,893,000$-51,044,000$-39,500,000$-84,623,000
    EBIT$-23,442,000$-17,861,000$-22,085,000$-33,407,000$32.73M$-37,192,000$-52,888,000$-39,407,000$-41,793,000$-62,538,000$-51,206,000$-96,043,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TXG

    Government Contracts

    Gov Obligations (TTM)
    $6.69M
    Gov Obligations / Revenue
    1.0%
    Obligations YoY
    -29.1%
    Active Awards
    99
    New Awards (TTM)
    88
    Avg Remaining Term
    7.5 mo

    Top agency: Department of Health and Human Services at 77.2% of trailing twelve month obligations across 4 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C24126P0349Department of Veterans AffairsDepartment of Veterans Affairs$349999Jun 15, 2026
    36C24225P1431Department of Veterans AffairsDepartment of Veterans Affairs$334143Sep 10, 2025
    75N95D25F40047Department of Health and Human ServicesNational Institutes of Health$249991Sep 25, 2025
    75N93025P01086Department of Health and Human ServicesNational Institutes of Health$249964Sep 29, 2025
    75N95D25F40028Department of Health and Human ServicesNational Institutes of Health$249934Aug 18, 2025
    75N95D25F40044Department of Health and Human ServicesNational Institutes of Health$249785Sep 24, 2025
    75N95D25F40021Department of Health and Human ServicesNational Institutes of Health$247506Aug 1, 2025
    75N95D25F40045Department of Health and Human ServicesNational Institutes of Health$246535Sep 25, 2025
    75N95D25F40029Department of Health and Human ServicesNational Institutes of Health$243284Aug 18, 2025
    75N95D25F40035Department of Health and Human ServicesNational Institutes of Health$208360Sep 19, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    10x Genomics (NASDAQ: TXG) holder to sell 2,207 RSU shares

    Shehnaaz Suliman, a holder of 10x Genomics (NASDAQ: TXG), plans to sell 2,207 shares of Class A common stock acquired through RSU vesting, with J.P. Morgan Securities LLC handling the sale. The aggregate market value of these shares is $143,719.84. This Form 144 filing also notes Suliman previously sold 5,723 shares for $186,756.21 within the last three months.

    Stock Titan•8/24/26•
    Neutral

    10x Genomics (TXG) CEO gifts 4,000 shares in stock donation

    10x Genomics, Inc. CEO Serge Saxonov reported a bona fide gift of 4,000 shares of Class A Common Stock on August 20, 2026. After this transaction, he directly holds 1,104,380 Class A shares and has indirect holdings through several family trusts where he serves as trustee. The gift was made without expectation of repayment and was not part of a Rule 10b5-1 trading plan.

    Stock Titan•8/24/26•
    Neutral

    Price to sales forward of 10x Genomics Inc Class A – MUN:1KJ

    This page provides financial information for 10x Genomics Inc Class A (MUN:1KJ) on the Munich Stock Exchange, specifically focusing on its forward price-to-sales ratio. The content is primarily a navigation and information hub, indicating the stock market status and various available financial tools and data provided by TradingView and its partners.

    TradingView•8/23/26•
    Neutral

    ETFs Investing in 10x Genomics Inc Class A Stocks

    This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold 10x Genomics Inc Class A stocks, organized by market value. It details various ETFs, including their issuers, management styles, expense ratios, AUM, price changes, and 3-year NAV total returns, offering investors a broad overview of investment options for this stock.

    TradingView•8/22/26•
    Neutral

    10x Genomics (NASDAQ: TXG) director sells under 10b5-1 plan

    10x Genomics (NASDAQ: TXG) director Sarah A. Teichmann reported two open-market sales of Class A Common Stock, totaling 7,551 shares. These transactions, executed on August 13 and August 14, 2026, were conducted under a Rule 10b5-1 trading plan adopted on May 14, 2026. The sales amounted to approximately $432,000, leaving Teichmann with 28,058 shares of Class A Common Stock.

    Stock Titan•8/17/26•
    Somewhat-Bearish

    Frequently Asked Questions About TXG

    Does TXG pay dividends?
    10X Genomics Inc (TXG) does not currently pay a regular dividend.
    What is TXG's market cap?
    10X Genomics Inc (TXG) has a market capitalization of $8.02B with a current stock price of $62.45.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In